The List: Most Popular Acute Care Hospitals
Information was obtained from firm representatives. Information on The List was supplied by individual companies through questionnaires and could not be independently verified by the Wichita Business Journal. Kansas Medical Center, Rock Regional Hospital, Sumner County Hospital, and Susan B. Allen Memorial Hospital did not respond to our inquiries by deadline. Only those that responded to our inquiries were listed. In case of ties, companies are listed alphabetically. The Wichita area includes Sedgwick, Butler, Harvey, and Sumner counties. If you wish to be surveyed when The List is next updated, or if you wish to be consi...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Source Type: news

Nasdaq notifies SmileDirectClub it is not in compliance with minimum price requirement
SmileDirectClub has 180 calendar days, or until May 17, to regain compliance by reaching a $1 per share or above closing stock price for a minimum of 10 consecutive days. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Construction resumes at Ohio State Wexner Medical tower after repairs to cracked column
"Following detailed structural inspections and repair work that has taken place to date, the contractor and engineers have determined that work can safely resume in the remainder of the facility," a university spokesman said. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

FDA Approves First Gene Therapy, Hemgenix, for Adults With Hemophilia B
MONDAY, Nov. 28, 2022 -- The U.S. Food and Drug Administration has approved Hemgenix (etranacogene dezaparvovec) for the treatment of hemophilia B in adults. Hemgenix, an adeno-associated virus vector-based gene therapy, is administered via... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Clinical Report Addresses Need for POCUS Guidelines for NICU
MONDAY, Nov. 28, 2022 -- A point-of-care ultrasonography (POCUS) program should be developed for use in the neonatal intensive care unit (NICU), according to a clinical report published online Nov. 28 in Pediatrics. Noting that use of POCUS in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

QOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma
MONDAY, Nov. 28, 2022 -- For patients with high-risk resected melanoma, adjuvant pembrolizumab improves quality of life (QOL) compared with standard of care with ipilimumab or high-dose interferonα 2b (HDI), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Asthma Exacerbations Up After Relaxation of COVID-19 Restrictions
MONDAY, Nov. 28, 2022 -- Relaxation of COVID-19 restrictions was associated with an increase in the incidence of COVID-19, non-COVID-19 acute respiratory infections (ARIs), and severe asthma exacerbations, according to a study published online Nov.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Cervical Cancer Incidence Up Among Women Ages 30 to 34 Years
MONDAY, Nov. 28, 2022 -- Between 2001 and 2019, cervical cancer incidence declined or remained stable among U.S. women except for those in the 30- to 34-year-old age group, according to a research letter published online Nov. 21 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Vitamin D Supplementation Does Not Influence Growth in Children
MONDAY, Nov. 28, 2022 -- For children with a high prevalence of vitamin D deficiency (25-hydroxyvitamin D [25(OH)D]<20 ng/mL), vitamin D3 supplementation increases 25(OH)D concentrations but does not influence growth, body composition, or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Robotic Resection Cuts Perioperative Morbidity With Liver Cancer
MONDAY, Nov. 28, 2022 -- Robotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

E-Cigarettes, Vaping Tied to Higher Cavity Risk
MONDAY, Nov. 28, 2022 -- Electronic cigarette or vaping users have a higher risk for developing dental caries, according to a study published in the December issue of the Journal of the American Dental Association. Karina F. Irusa, from the Tufts... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

Benzodiazepines Tied to Drug Overdose in Young People With Sleep Disorders
MONDAY, Nov. 28, 2022 -- Benzodiazepines are associated with an increased risk for drug overdose among young people versus alternative pharmacologic treatments for common sleep disorders, according to a study published online Nov. 22 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2022 Category: Pharmaceuticals Source Type: news

I-Drive medical marijuana dispensary to reopen after two-year absence
The dispensary had closed during the start of the Covid-19 pandemic. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: Ryan Lynch Source Type: news

AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M
AstraZeneca entered into a multimillion-dollar licensing deal Monday giving it worldwide exclusive rights to develop and commercialize an oral therapy under development as a potential treatment for chronic obstructive pulmonary disease (COPD) and other inflammatory and respiratory diseases. Under the financial terms of the deal, AstraZeneca (NYSE: AZN) will make an upfront payment of $2 million to C4X Discovery Holdings (AIM: C4XD), a drug discovery company with offices in Manchester and London, … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment
A Fort Washington pharmaceutical company's stock opened up 9% Monday after it posted positive early stage clinical trial results from testing of its antibiotic Xenleta as a potential treatment for cystic fibrosis. Nabriva Therapeutics' stock was trading up about 13% at $2.45 per share in early morning trading. Cystic fibrosis is a progressive, genetic disease that causes severe damage to the lungs, digestive system, and other organs. It can cause frequent lung infections including pneumonia or … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2022 Category: Pharmaceuticals Authors: John George Source Type: news